Enter your login e-mail to the account
Search
- Rosuvastatín: nový inhibítor 3-hydroxy-3-methylglutaryl koenzým a reduktázy
doc. MUDr. Martin Gajdoš,CSc., MUDr. Ľubica Cibulová, RNDr. Zora Krivošíková, PhD.,
(1/2004, Medicine )
- Partial dopamine agonism as a next antipsychotic generation concept?
MUDr. Jozef Dragašek, PhD.
(3/2015, Psychopharmacology )
- Gastrointestinálne a nutričné problémy pri poruchách autistického spektra a ich riešenie
MUDr. Katarína Babinská, PhD., MSc., Mgr. Diana Filčíková, prof. MUDr. Daniela Ostatníková, PhD., MUDr. Dagmar Nemcsicsová
(2/2018, Review articles )
- Management of pacients with CML resistant or intolerant to tyrosine kinase inhibitor – imatinib
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Juraj Halička, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD.
(4/2012, Topic of the year ) - First line treatment of metastatic renal cell cancer in 2014
MUDr. Mária Rečková
(4/2014, Main topic ) - The incidence and management of side effects of tyrosinekinase inhibitors for treatment of chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2015, Review articles )












